Author:
Goldstein D.,Borden E. C.
Reference45 articles.
1. Cerosimi RJ and Hong WK: Epirubicin: A review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol 4:425–439, 1986.
2. Lopez M, Carpano S, Vici P, Di Laurol L, Papaldo P: Epirubicin and DTIC (EDIC) in the treatment of advanced soft tissue sarcomas in adults (abstr.) Proc Am Soc Clin Oncol 6:256, 1987.
3. Adams WJ, Brewer JE, Hosley JD, Earhart RH, Kuhn J, Weiss G, Brown T: Systemic Bioavailability and Pharmacokinetics of orally administered Menogaril. Proc Am Assoc Cancer Res 28:195, 1987.
4. Sordillo PP, Magill GB, Brenner J, Cheng EW, Dosik M, Yagoda A: Cisplatin. A Phase II evaluation in previously untreated patients with soft tissue sarcoma. Cancer 59:884–886, 1987.
5. Brenner J, Magill GB, Sordillo PP, Cheng EW, Yagoda A: A Phase II trial of cisplatin (CDDP) in previously treated patients with advanced soft tissue sarcoma. Cancer 50:2031–2033, 1982.